Product image of Aridol (Mannitol) supplied by GNH India

Aridol

Active Ingredient:
Mannitol
Origin:
EU

Aridol (Mannitol)

Aridol (Mannitol) is an inhalation powder used for bronchial challenge testing. Learn about its uses, effects, and precautions here.

Manufacturer / TM Owner

Pharmaxis Europe Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Aridol (Mannitol) is primarily used as a diagnostic tool in bronchial challenge testing. This test helps assess airway hyperresponsiveness, which can be indicative of conditions like asthma. By inhaling Mannitol, healthcare professionals can observe how the airways react, providing insights into respiratory health. Aridol is not intended for therapeutic use but rather for diagnostic purposes.

Side Effects

  • When inhaled, Aridol (Mannitol) can cause temporary airway constriction, which is monitored during the bronchial challenge test. This effect helps determine the sensitivity of the airways. Common effects may include coughing or shortness of breath, which are typically managed under medical supervision during the test.

Precautions & Warnings

  • Aridol (Mannitol) should be used strictly under medical supervision. Individuals with severe respiratory conditions should exercise caution. It is important to follow the healthcare provider's instructions carefully to ensure safe and accurate testing. Always inform your healthcare provider of any existing respiratory conditions or allergies before using Aridol.

Avoid Interactions

  • Aridol (Mannitol) may interact with other respiratory medications. It is important to inform your healthcare provider about all medications you are taking before undergoing a bronchial challenge test with Aridol. This includes any inhalers, bronchodilators, or other respiratory treatments.

Frequently Asked Questions

Aridol is used for bronchial challenge testing to assess airway hyperresponsiveness, often in the diagnosis of conditions like asthma.

Aridol is administered via inhalation using a specialized inhaler device under medical supervision.

Common effects include temporary airway constriction, coughing, or shortness of breath, which are monitored during the test.

No, Aridol is strictly for diagnostic use in bronchial challenge testing and not intended for therapeutic treatment.

Yes, Aridol should be used under medical supervision, and individuals with severe respiratory conditions should exercise caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mannitol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT